FDA Inspection 1225275 - Janssen Pharmaceuticals Inc. - December 14, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Janssen Pharmaceuticals Inc., with an inspection on December 14, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Janssen Pharmaceuticals Inc.
Inspection Date: December 14, 2023
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · f5eb5852-3f6a-4246-a387-cf35044c8d21

Violation Codes4

21 CFR 211.160(b)21 CFR 211.25(a)21 CFR 211.67(a)21 CFR 600.14(a)(1)

Full citation text and observation details available on the Dashboard.